Instalab

Acarus Siro IgE Test Blood

See whether a hidden storage mite is driving your year-round sneezing, asthma, or skin flares.

Should you take a Acarus Siro IgE test?

This test is most useful if any of these apply to you.

Sneezing or Wheezing in Dusty Spaces
You get nasal congestion or breathing trouble in barns, kitchens, basements, or around stored food, and want to know if a storage mite is the trigger.
Working with Grain or Flour
You're a farmer, baker, or grain handler. Up to 38% of farmers with respiratory symptoms test positive for storage mite allergy.
Already Allergic to Dust Mites
Your dust mite allergy is known, but symptoms don't fully add up. A storage mite sensitization may be adding fuel that a standard panel missed.
Eczema or Asthma That Won't Settle
Your skin or breathing keeps flaring despite treatment. Mapping every mite trigger, including storage mites, can pinpoint what's driving the inflammation.

About Acarus Siro IgE

If you have year-round allergy symptoms that flare in dusty environments, around stored grains, or in barns and bakeries, a standard house dust mite test may not be enough. Acarus siro is a different creature, a storage mite that thrives in flour, hay, animal feed, and damp pantry corners, and your body can react to it independently of common dust mites.

This test looks for IgE antibodies (the immune protein behind classic allergic reactions) that specifically recognize Acarus siro proteins. A positive result tells you your immune system has been primed to react to this mite, which can show up as rhinitis, asthma, or worsening eczema.

What This Test Actually Measures

Acarus siro IgE is an antibody your immune system makes after recognizing proteins from this storage mite as a threat. The antibody is produced by specialized white blood cells called B cells, and once it is made, it can attach to mast cells and basophils, the immune cells that release histamine and other chemicals during an allergic reaction.

The presence of this antibody means your immune system has been sensitized to Acarus siro. Sensitization is not the same as a clinical allergy. Some people have a detectable antibody without symptoms. But when sensitization lines up with real-world exposure and real-world symptoms, the IgE result is what links the symptom to the trigger.

Why Storage Mites Are Easy to Miss

Most allergy panels focus on the two common house dust mites, Dermatophagoides pteronyssinus and Dermatophagoides farinae. Storage mites like Acarus siro live in different environments and produce overlapping but distinct allergens. In one study of 196 urban adults, 14% had detectable IgE to at least one storage mite, including Acarus siro, even without occupational exposure to grain or flour.

Storage mite sensitization is especially common in people who work with grain or food. In a survey of 3,018 farmers on the Swedish island of Gotland, storage mite allergy was found in 6.2% of the whole farming population and in 37.8% of farmers with respiratory symptoms suggesting an IgE-driven allergy. Among Danish grain elevator workers, 15.9% were sensitized to storage mites and 6.4% had respiratory storage mite allergy.

Allergic Rhinitis and Asthma

Acarus siro IgE shows up most often in people with allergic rhinitis or asthma. In a study of 130 allergic rhinitis patients in Central China who were already known to react to house dust mite, 81.5% also had IgE to Acarus siro. The Acarus siro antibody levels in that group were typically lower than those for the two main house dust mites but still relevant to the clinical picture.

In a Northern European cohort of 1,180 people, storage mite allergy was about as common as house dust mite allergy and was independently associated with respiratory symptoms and asthma. In other words, storage mite sensitization carried its own risk signal, not just a shadow of dust mite allergy.

Among asthmatic children in Haikou, southern China, IgE to Acarus siro was part of a broader mite sensitization pattern. In that group, higher overall mite-specific IgE tracked with markers of active allergic airway inflammation, including blood eosinophil counts and exhaled nitric oxide, a breath test for airway inflammation.

Atopic Dermatitis and Skin Disease

Mite sensitization is also tied to eczema. In a study of 384 patients, IgE to specific dust mite proteins (including Der p 20) was linked to severe atopic dermatitis. The pattern is consistent: people whose immune systems are broadly reactive to mite allergens, including storage mites, are more likely to experience worse skin flares, alongside their nasal and breathing symptoms.

Polysensitization and Why Severity Climbs

Reacting to multiple allergens at once tends to make symptoms worse. In a cohort of 500 allergic patients, 81% were polysensitized (reactive to multiple allergens), and polysensitization was associated with more severe asthma and rhinitis. If Acarus siro IgE turns up on your panel alongside house dust mite, pollen, or animal dander reactivity, that combination matters: each added sensitization tends to compound the symptom load.

The Cross-Reactivity Question

One reason this result is easy to misinterpret is cross-reactivity. House dust mites and storage mites share some protein structures, so an antibody made against one can sometimes bind the other. In an early urban cohort, every person with storage mite IgE also had house dust mite IgE, and inhibition experiments showed considerable cross-reactivity between Dermatophagoides pteronyssinus and Acarus siro.

But cross-reactivity is not the whole story. In a separate study of 600 people in Ohio, binding patterns suggested limited cross-reactivity between Acarus siro and other storage mites, indicating that some people are independently sensitized to Acarus siro itself. The practical implication: a positive Acarus siro IgE may reflect a true, independent storage mite allergy, particularly if you have exposure to flour, grain, hay, or stored food, or it may be largely a cross-reaction with a dominant house dust mite allergy. Sorting that out usually requires looking at the whole panel and your exposure history together.

Tracking Your Trend

A single IgE reading is a snapshot. Specific IgE antibodies rise and fall over months and years based on exposure, treatment, and immune state. In a three-year study of allergen immunotherapy patients, dust mite IgE went up at first and then dropped significantly, and IgE to a non-target allergen (Artemisia pollen) also decreased modestly, showing that the immune system shifts over time in ways that one lab draw cannot capture.

The most useful approach is to establish a baseline now, retest in three to six months if you are starting an intervention like environmental control or immunotherapy, and then at least annually if symptoms continue. A trend tells you whether the immune system is calming down, holding steady, or escalating, which is far more actionable than any single number.

What to Do With an Unexpected Result

A positive Acarus siro IgE result should make you investigate, not panic. Ask three questions. First, do your symptoms match storage mite exposure? Rhinitis or asthma that worsens in barns, kitchens with old flour, basements, or while handling grain or pet food is a clue. Second, what does the rest of your allergy panel look like? If your house dust mite IgE is high and Acarus siro is roughly proportional, cross-reactivity may explain part of the signal. If Acarus siro stands alone or is disproportionately elevated, an independent storage mite allergy is more likely.

Third, who should you talk to? An allergist or immunologist is the right specialist for sorting out which sensitizations are clinically relevant, whether component-resolved testing (looking at individual mite proteins rather than the whole extract) would help, and whether allergen-specific immunotherapy makes sense. The goal is to confirm whether the antibody is driving real symptoms and to match the treatment to the specific trigger.

When Results Can Be Misleading

A few situations can make a single Acarus siro IgE reading harder to interpret:

  • Cross-reactivity with house dust mite: if your dust mite IgE is high, a positive Acarus siro result may partly reflect antibody binding to shared proteins rather than independent storage mite allergy.
  • Recent biologic therapy: treatments like dupilumab, a biologic drug that blocks the IL-4 and IL-13 immune signals, can significantly reduce both total IgE and specific IgE to multiple mite allergens over 52 weeks. If you are on a biologic, your IgE numbers may underestimate your underlying sensitization.
  • Ongoing allergen immunotherapy: IgE often rises in the first months of immunotherapy before falling. A reading taken during this transition can be misleading if you do not know where in the timeline you are.
  • Sensitization without symptoms: detectable IgE means your immune system recognizes the allergen, but it does not by itself prove that this allergen is causing your symptoms. Clinical correlation always matters.

How This Compares to Standard Allergy Tests

Most allergy panels prioritize house dust mites, and many stop there. If you have storage mite exposure and a panel that did not include Acarus siro, you may have a real trigger flying under the radar. In one study of children, three common specific IgE assay platforms gave similar diagnostic performance for major aeroallergens like dust mite, but expanding the panel did not always improve clinical utility, meaning the test only adds value when the result actually changes what you do.

For Acarus siro specifically, the test is most useful when you have unexplained allergy symptoms, occupational or home exposure to grain or stored food, or a known dust mite allergy that is not fully explained by your standard panel. It is not a routine screening test for asymptomatic people.

What Moves This Biomarker

Evidence-backed interventions that affect your Acarus Siro IgE level

↕ Up & Down
House dust mite allergen-specific immunotherapy
This is the only treatment shown to retrain your immune response to mite allergens rather than just suppress symptoms. In a three-year study of patients on house dust mite immunotherapy, dust mite specific IgE rose in the first months and then fell significantly by year three, alongside a smaller drop in IgE to non-target allergens, suggesting broader immune modulation. Direct effects on Acarus siro IgE specifically have not been measured in these trials.
MedicationStrong Evidence
↓ Decrease
Dupilumab, a biologic drug that blocks the IL-4 and IL-13 immune signals
Over 52 weeks of treatment for severe atopic dermatitis, dupilumab significantly reduced total IgE and specific IgE to multiple house dust mite and storage mite allergens, including Lep d 2 from a related storage mite. The Acarus siro response was not separately reported, but the broad mite-IgE reduction suggests it likely behaves similarly. Be aware that this reduction may make IgE testing less reliable for assessing true sensitization while on therapy.
MedicationStrong Evidence
↑ Increase
Occupational exposure to grain, flour, hay, or stored food
Working with stored grains and food substantially raises your odds of developing storage mite sensitization. In a survey of 3,018 farmers, 6.2% of the entire farming population had storage mite allergy, climbing to 37.8% in farmers with respiratory symptoms. Among 139 Danish grain elevator workers, 15.9% were sensitized to storage mites. If your exposure is unavoidable, this is the population where Acarus siro IgE testing has the highest yield.
LifestyleStrong Evidence

Frequently Asked Questions

References

15 studies
  1. Yadav a, Elder B, Morgan M, Vyszenski-moher D, Arlian LAnnals of Allergy, Asthma & Immunology2006
  2. Tee R, Gordon DJ, Hage-hamsten M, Gordon S, Nunn a, Johansson S, Taylor AJClinical & Experimental Allergy1992
  3. Yang Y, Zhu R, Huang N, Li W, Zhang W, Wang Y, Yang LAmerican Journal of Rhinology & Allergy2018
  4. Indoor Mite Allergen Levels, Specific IgE Prevalence and IgE Cross-inhibition Pattern Among Asthmatic Children in Haikou, Southern China.
    Zheng Y, Chen S, Lai X, Gjesing B, Zhong N, Spangfort MChinese Medical Journal2012